Literature DB >> 24523294

A fatality involving AH-7921.

Shawn P Vorce1, Jessica L Knittel, Justin M Holler, Joseph Magluilo, Barry Levine, Philip Berran, Thomas Z Bosy.   

Abstract

A case is presented of a 19-year-old white male who was found dead in bed by a friend. While no anatomic cause of death was observed at autopsy, toxicological analysis of his blood identified AH-7921, a synthetic opioid. AH-7921 was isolated by liquid-liquid extraction into n-butyl chloride from alkalinized samples. Extracts were analyzed and quantified by gas chromatography mass spectrometry in selected ion monitoring mode. The heart blood had an AH-7921 concentration of 3.9 mg/L and the peripheral blood concentration was 9.1 mg/L. In addition to the blood, all submitted postmortem specimens including urine, liver, kidney, spleen, heart, lung, brain, bile and stomach content were quantified. The following concentrations of AH-7921 were reported: 6.0 mg/L in urine, 26 mg/kg in liver, 7.2 mg/kg in kidney, 8.0 mg/kg in spleen, 5.1 mg/kg in heart, 21 mg/kg in lung, 7.7 mg/kg in brain, 17 mg/L in bile and 120 mg/125 mL in the stomach content. The medical examiner reported that the cause of death was opioid intoxication and the manner of death was accident.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24523294     DOI: 10.1093/jat/bku011

Source DB:  PubMed          Journal:  J Anal Toxicol        ISSN: 0146-4760            Impact factor:   3.367


  10 in total

1.  Metabolic characterization of AH-7921, a synthetic opioid designer drug: in vitro metabolic stability assessment and metabolite identification, evaluation of in silico prediction, and in vivo confirmation.

Authors:  Ariane Wohlfarth; Karl B Scheidweiler; Shaokun Pang; Mingshe Zhu; Marisol Castaneto; Robert Kronstrand; Marilyn A Huestis
Journal:  Drug Test Anal       Date:  2015-09-01       Impact factor: 3.345

Review 2.  AH-7921: A review of previously published reports.

Authors:  Kerry Anne Rambaran; Zubair M Amin; Steven W Fleming; Liza Chacko; Saeed K Alzghari
Journal:  Proc (Bayl Univ Med Cent)       Date:  2018-06-01

Review 3.  Blood concentrations of new synthetic opioids.

Authors:  Piotr Adamowicz; Karolina Nowak
Journal:  Int J Legal Med       Date:  2021-10-22       Impact factor: 2.686

4.  AH-7921: the list of new psychoactive opioids is expanded.

Authors:  Maria Katselou; Ioannis Papoutsis; Panagiota Nikolaou; Chara Spiliopoulou; Sotiris Athanaselis
Journal:  Forensic Toxicol       Date:  2015-02-21       Impact factor: 4.096

Review 5.  An Expanding World of Novel Psychoactive Substances: Opioids.

Authors:  Jolanta B Zawilska
Journal:  Front Psychiatry       Date:  2017-06-30       Impact factor: 4.157

Review 6.  Postmortem Toxicology of New Synthetic Opioids.

Authors:  Marta Concheiro; Rachel Chesser; Justine Pardi; Gail Cooper
Journal:  Front Pharmacol       Date:  2018-10-26       Impact factor: 5.810

Review 7.  Non-Medical Use of Novel Synthetic Opioids: A New Challenge to Public Health.

Authors:  Barbara Lovrecic; Mercedes Lovrecic; Branko Gabrovec; Marco Carli; Matteo Pacini; Angelo G I Maremmani; Icro Maremmani
Journal:  Int J Environ Res Public Health       Date:  2019-01-09       Impact factor: 3.390

Review 8.  An updated review on synthetic cathinones.

Authors:  Jorge Soares; Vera Marisa Costa; Maria de Lourdes Bastos; Félix Carvalho; João Paulo Capela
Journal:  Arch Toxicol       Date:  2021-06-08       Impact factor: 5.153

Review 9.  Designer drugs: mechanism of action and adverse effects.

Authors:  Dino Luethi; Matthias E Liechti
Journal:  Arch Toxicol       Date:  2020-04-06       Impact factor: 5.153

Review 10.  Novel Synthetic Opioids: The Pathologist's Point of View.

Authors:  Paolo Frisoni; Erica Bacchio; Sabrine Bilel; Anna Talarico; Rosa Maria Gaudio; Mario Barbieri; Margherita Neri; Matteo Marti
Journal:  Brain Sci       Date:  2018-09-02
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.